David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CALL
Cisco
CSCO
$438B
| $63.4M | 0.09% |
1,656,300
-85,100
| -5% | -$3.04M |
|
|
EGN
277
DELISTED
Energen
EGN
| $63.3M | 0.09% |
1,100,318
+80,486
| +8% | +$4.37M |
|
278
PUT
Bristol-Myers Squibb
BMY
$137B
| $63.1M | 0.09% |
1,029,700
+64,700
| +7% | +$4.05M |
|
279
Intuitive Surgical
ISRG
$134B
| $62.9M | 0.09% |
517,293
+317,007
| +158% | +$39.7M |
|
|
XYZ
280
PUT
Block Inc
XYZ
$49.4B
| $62.9M | 0.09% |
1,815,000
+1,255,000
| +224% | +$46M |
|
281
Vertex Pharmaceuticals
VRTX
$139B
| $62.9M | 0.09% |
419,650
+95,561
| +29% | +$14.1M |
|
282
Oracle
ORCL
$422B
| $62.8M | 0.09% |
1,328,169
+479,065
| +56% | +$23.5M |
|
283
Costco
COST
$420B
| $62.6M | 0.09% |
336,357
-78,633
| -19% | -$13.6M |
|
|
284
Verizon
VZ
$205B
| $62.3M | 0.09% |
1,177,561
-4,779,603
| -80% | -$235M |
|
285
Bruker
BRKR
$9.07B
| $61.8M | 0.09% |
1,800,775
+222,160
| +14% | +$7.28M |
|
|
NUAN
286
DELISTED
Nuance Communications, Inc.
NUAN
| $61.6M | 0.08% |
4,353,465
+2,054,585
| +89% | +$27.6M |
|
|
MON
287
CALL
DELISTED
Monsanto Co
MON
| $61.5M | 0.08% |
526,500
-36,900
| -7% | -$4.39M |
|
|
CELG
288
PUT
DELISTED
Celgene Corp
CELG
| $61.3M | 0.08% |
587,300
+571,400
| +3,594% | +$64.5M |
|
289
US Bancorp
USB
$96.7B
| $61.2M | 0.08% |
1,142,749
-128,738
| -10% | -$6.93M |
|
290
Palo Alto Networks
PANW
$292B
| $61.2M | 0.08% |
2,532,882
-622,908
| -20% | -$15.2M |
|
|
VSM
291
DELISTED
Versum Materials, Inc.
VSM
| $61M | 0.08% |
1,611,110
-107,053
| -6% | -$4.17M |
|
292
Post Holdings
POST
$3.65B
| $60.8M | 0.08% |
1,171,710
+277,931
| +31% | +$14.8M |
|
|
APC
293
PUT
DELISTED
Anadarko Petroleum
APC
| $60.3M | 0.08% |
1,123,700
+167,600
| +18% | +$8.24M |
|
294
Carlisle Companies
CSL
$14.6B
| $60.2M | 0.08% |
529,286
+13,731
| +3% | +$1.5M |
|
|
HTZ
295
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $59.7M | 0.08% |
3,107,700
+203,221
| +7% | +$3.93M |
|
296
CALL
Biogen
BIIB
$32B
| $59M | 0.08% |
185,100
+53,300
| +40% | +$17.1M |
|
297
Yum China
YUMC
$16.9B
| $58.8M | 0.08% |
1,470,487
+708,053
| +93% | +$29.1M |
|
298
BlackBerry
BB
$4.71B
| $58.3M | 0.08% |
5,216,488
+2,100,349
| +67% | +$22.9M |
|
299
PUT
Morgan Stanley
MS
$336B
| $58.1M | 0.08% |
1,107,100
+24,100
| +2% | +$1.22M |
|
300
NextEra Energy
NEE
$174B
| $58M | 0.08% |
1,484,748
-591,120
| -28% | -$22.8M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.